Journal of the American Chemical Society · 2012 · 47 citations · 45 references
Natural SciencesBiomedical EngineeringMaterials ScienceBiomaterialsMolecular ImagingNanomaterialsContrast AgentsContrast MediaInorganic NanoparticlesMagnetic Resonance ImagingNanomedicineTargeted Imaging AgentsMagnetic Resonance Imaging Contrast AgentsMesoporous Silica NanomaterialsMesoporous Silica NanoparticlesMicroparticlesNanoparticle Contrast AgentsNanoparticle Imaging AgentsPorous SilicaSilica-based Nanoparticles
Particle-based magnetic resonance imaging (MRI) contrast agents have been the focus of recent studies, primarily due to the possibility of preparing multimodal particles capable of simultaneously targeting, imaging, and treating specific biological tissues in vivo. In addition, particle-based MRI contrast agents often have greater sensitivity than commercially available, soluble agents due to decreased molecular tumbling rates following surface immobilization, leading to increased relaxivities. Mesoporous silica particles are particularly attractive substrates due to their large internal surface areas. In this study, we immobilized a unique phosphonate-containing ligand onto mesoporous silica particles with a range of pore diameters, pore volumes, and surface areas, and Gd(III) ions were then chelated to the particles. Per-Gd(III) ionic relaxivities ranged from ∼2 to 10 mM(-1) s(-1) (37 °C, 60 MHz), compared to 3.0-3.5 mM(-1) s(-1) for commercial agents. The large surface areas allowed many Gd(III) ions to be chelated, leading to per-particle relaxivities of 3.3 × 10(7) mM(-1) s(-1), which is the largest value measured for a biologically suitable particle.
45
Ji Eun Lee, Nohyun Lee, Hyoungsu Kim et al. · Journal of the American Chemical Society · 2009 · 703 citations
Christophe Alric, Jacqueline Taleb, Géraldine Le Duc et al. · Journal of the American Chemical Society · 2008 · 520 citations · Full text